Zurcher Kantonalbank Zurich Cantonalbank Buys 148 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Zurcher Kantonalbank Zurich Cantonalbank raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,873 shares of the exchange traded fund’s stock after acquiring an additional 148 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in SPDR S&P Biotech ETF were worth $2,373,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $141,284,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of SPDR S&P Biotech ETF by 1.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after acquiring an additional 18,202 shares during the period. Mirae Asset Securities USA Inc. grew its stake in shares of SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares in the last quarter. Finally, Employees Retirement System of Texas increased its position in SPDR S&P Biotech ETF by 40.8% during the second quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after acquiring an additional 174,857 shares during the period.

SPDR S&P Biotech ETF Stock Down 1.6 %

NYSEARCA XBI opened at $97.69 on Wednesday. The firm has a 50-day moving average price of $98.22 and a two-hundred day moving average price of $96.69. SPDR S&P Biotech ETF has a 12-month low of $77.21 and a 12-month high of $105.47. The company has a market capitalization of $7.45 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.